Slaughters and Cleary advise as GSK sells off half its stake sale in Aspen
This week has seen Slaughters amd May and Cleary Gottlieb advise GlaxoSmithKline as it slashed its shares in South African pharma company Aspen, selling off half of its 12.4 per cent stake for £574m. This deal gives GSK a reduced share (6.2 per cent) in the drug manufacturer, and much more cash in hand to […]